Lifecare ASA (STO:LIFEO)

Market Cap	67.19M -66.0%
Revenue (ttm)	6.07M -31.3%
Net Income	-109.29M
EPS	-6.22
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,382
Average Volume	3,201
Open	0.4000
Previous Close	n/a
Day's Range	0.4000 - 0.4000
52-Week Range	0.4000 - 18.1000
Beta	n/a
RSI	36.40
Earnings Date	Mar 3, 2026

About Lifecare ASA

Lifecare ASA, together with its subsidiaries, operates as a medical sensor company that develops technology for sensing and monitoring of various body analytes in Norway. The company develops Sencell, a micro sensor for monitoring glucose levels in patients with diabetes and for veterinary applications. It also develops and manufactures a nanostrain biosensor, an ultra-small device that measures pressure, temperature, force, or various other performance indicators in live tissue; and medical devices that remove subdermal implants. Lifecare ASA ...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2006
• Employees: 28
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: LIFEO

Financial Performance

In 2025, Lifecare ASA's revenue was 6.64 million, a decrease of -31.34% compared to the previous year's 9.67 million. Losses were -119.53 million, 66.6% more than in 2024.

Financial numbers in NOK